Angelicin Mitigating Renal Fibrosis and Treating IgA Nephropathy via the ESR1-FOS Pathway

Hejing Fang, Ling Zhou, Xuchun Xu, Tingting Zhang, Shuangqing Li, Can Jin

PDF(6018 KB)
For Authors|For Editors|For Reviewers
PDF(6018 KB)
Discovery Medicine ›› 2025, Vol. 37 ›› Issue (201) : 2214-2223. DOI: 10.24976/Discov.Med.202537201.188
Article

Angelicin Mitigating Renal Fibrosis and Treating IgA Nephropathy via the ESR1-FOS Pathway

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

Highlight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 37(201): 2214-2223 https://doi.org/10.24976/Discov.Med.202537201.188

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(6018 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2025.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    • /

    〈 〉